Abnormally enhanced blood concentrations of vascular endothelial growth factor (VEGF) in metastatic cancer patients and their relation to circulating dendritic cells, IL-12 and endothelin-1

Journal of Biological Regulators and Homeostatic Agents

Volumn 15, Issue 2, 2001, Pages 140-144

  Lissoni, P ^a   Malugani, F ^a   Bonfanti, A ^a   Bucovec, R ^a   Secondino, S ^a   Brivio, F ^a   Ferrari Bravo, A ^a   Ferrante, R ^a   Vigore, L ^a   Rovelli, F ^a   Mandala, M ^a   Vivian, S ^a   Fumagalli, L ^a   Gardani, G S ^a  

^a SAN GERARDO HOSPITAL   (Italy)

Author keywords

Angiogenesis; Dendritic cells; Endothelin 1; Immunosuppression; Interleukin 12

Indexed keywords

CD11 ANTIGEN; CD123 ANTIGEN; ENDOTHELIN 1; INTERLEUKIN 12; LYMPHOCYTE ANTIGEN; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN 165;

ADULT; ADVANCED CANCER; AGED; ANGIOGENESIS; ARTICLE; BLOOD LEVEL; BREAST CANCER; CELL MATURATION; COLORECTAL CANCER; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DENDRITIC CELL; FEMALE; FEMALE GENITAL TRACT TUMOR; HUMAN; IMMUNE DEFICIENCY; KIDNEY CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PANCREAS CANCER; PROGNOSIS; SOLID TUMOR; STOMACH CANCER;

EID: 0034883882     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Cancer, cytokines and cytotoxic cells: Interleukin-2 in the immunotherapy of human neoplasms
2. Role of pro- and anti-inflammatory cytokines during inflammation: Experimental and clinical findings
3. Angiogenesis
4. The immunotherapy and gene therapy of cancer
5. Novel growth regulatory factors and tumor angiogenesis
6. Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: Significance of VEGF measurements and cancer biology
7. The vascular endothelial growth factor family of polypeptides
8. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells
9. The dendritic cell system and anti-tumor immunity. In vivo
10. Interleukin 12: A new clinical player in cytokine therapy
11. Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients
12. Serum vascular endothelial growth factor is often elevated in disseminated cancer
13. Growth regulatory properties of endothelins
14. Endothelin potentiates growth factor-stimulated DNA synthesis in Swiss 3T3 Cells
15. Endothelin-1 and tumor development
16. Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: Clinical implications
17. Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature
18. The role of interleukin-2, interleukin-12, and dendritic cells in cancer therapy